Benzonatate Capsule
Product Images NDC 65841-614

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 65841-614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

647424d0 F3b7 4128 8543 F0db0c994926 01

647424d0 F3b7 4128 8543 F0db0c994926 01
This text is a medication label for Benzonatate Capsules, USP with a strength of 100mg per capsule. The label provides information on how to store the medication, how it should be dispensed, and a warning to keep it out of reach of children. The National Drug Code (NDC) is 65841-61.*
FDA Label Image

647424d0 F3b7 4128 8543 F0db0c994926 02

647424d0 F3b7 4128 8543 F0db0c994926 02
NDC 65841-843-01 is the identifying code for Benzonatate Capsules, USP. Each capsule contains 20mg of Benzonatate and the package contains 100 capsules. The package insert should be consulted for complete prescribing information and the medication should be stored in a light-resistant container at controlled room temperature. The drug is manufactured in India by Cala Healthcare Ltd. It is important to keep all drugs, including this one, out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.